D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Molecular Biology D-index 63 Citations 14,120 216 World Ranking 1178 National Ranking 97

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • DNA

Hiromi Sakamoto focuses on Gene, Molecular biology, Cancer research, Genetics and Cancer. His work in the fields of Gene, such as Transcription, Oncogene, Gene cluster and Gene duplication, intersects with other areas such as INT. The various areas that Hiromi Sakamoto examines in his Molecular biology study include Gene expression, FGF10, Fibroblast growth factor receptor 3, Complementary DNA and Messenger RNA.

The concepts of his Cancer research study are interwoven with issues in Epidermal growth factor receptor, Gefitinib, Immunology, Lung cancer and Adenocarcinoma. Hiromi Sakamoto has included themes like KRAS and Lung in his Adenocarcinoma study. His Cancer research integrates issues from Case-control study and Oncology.

His most cited work include:

  • Epidermal Growth Factor Receptor Gene Mutations and Increased Copy Numbers Predict Gefitinib Sensitivity in Patients With Recurrent Non–Small-Cell Lung Cancer (654 citations)
  • KIF5B-RET fusions in lung adenocarcinoma. (603 citations)
  • Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas. (400 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Molecular biology, Gene, Cancer research, Internal medicine and Cancer. His study in Molecular biology is interdisciplinary in nature, drawing from both Cell culture, Gene expression, Complementary DNA, Fibroblast growth factor and Exon. In his study, Stomach is inextricably linked to DNA, which falls within the broad field of Gene.

His Cancer research research is multidisciplinary, incorporating elements of Carcinogenesis, Oncogene, Immunology, Regulation of gene expression and Adenocarcinoma. His Internal medicine study incorporates themes from Gastroenterology, Endocrinology and Oncology. His Cancer study integrates concerns from other disciplines, such as Single-nucleotide polymorphism, Exact test and Pathology.

He most often published in these fields:

  • Molecular biology (29.88%)
  • Gene (28.22%)
  • Cancer research (25.31%)

What were the highlights of his more recent work (between 2016-2021)?

  • Oncology (15.77%)
  • Internal medicine (20.75%)
  • microRNA (7.47%)

In recent papers he was focusing on the following fields of study:

Hiromi Sakamoto mainly investigates Oncology, Internal medicine, microRNA, Cancer and Cancer research. His studies deal with areas such as Area under the curve, Circulating MicroRNA, Retrospective cohort study, Esophageal cancer and Breast cancer as well as Oncology. His work on Taxane, Lung cancer, Liquid biopsy and Diagnostic biomarker as part of general Internal medicine research is frequently linked to Peripheral neuropathy, thereby connecting diverse disciplines of science.

Hiromi Sakamoto has included themes like Genome-wide association study, Single-nucleotide polymorphism, Glioma, Human genetics and Receiver operating characteristic in his Cancer study. He combines subjects such as Fusion gene, Gene, B cell, Immunophenotyping and Transplantation with his study of Cancer research. Many of his studies involve connections with topics such as ABO blood group system and Gene.

Between 2016 and 2021, his most popular works were:

  • Integrated extracellular microRNA profiling for ovarian cancer screening (84 citations)
  • ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype (70 citations)
  • A serum microRNA classifier for the diagnosis of sarcomas of various histological subtypes. (29 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • DNA

His primary areas of study are Internal medicine, Oncology, Cancer, microRNA and Cancer research. He studied Internal medicine and Circulating MicroRNA that intersect with Ovarian cancer screening, Diagnostic biomarker, Ovarian cancer and DNA microarray. His Lung cancer and T-stage study in the realm of Oncology connects with subjects such as Diagnostic model.

His research integrates issues of Computational biology, Formalin fixed paraffin embedded, DNA and Paraffin embedding in his study of Cancer. His microRNA research also works with subjects such as

  • Pathology and Benign disease most often made with reference to Serum samples,
  • Stage which is related to area like Area under the curve, Cirrhosis, Liver disease, Hepatocellular carcinoma and Pathological. His research in Cancer research is mostly concerned with Osteosarcoma.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

KIF5B-RET fusions in lung adenocarcinoma.

Takashi Kohno;Hitoshi Ichikawa;Yasushi Totoki;Kazuki Yasuda.
Nature Medicine (2012)

884 Citations

Epidermal Growth Factor Receptor Gene Mutations and Increased Copy Numbers Predict Gefitinib Sensitivity in Patients With Recurrent Non–Small-Cell Lung Cancer

Toshimi Takano;Yuichiro Ohe;Hiromi Sakamoto;Koji Tsuta.
Journal of Clinical Oncology (2005)

872 Citations

Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas.

Hirokazu Okayama;Takashi Kohno;Yuko Ishii;Yoko Shimada.
Cancer Research (2012)

640 Citations

Correlation between Long-Term Survival in Breast Cancer Patients and Amplification of Two Putative Oncogene-Coamplification Units: hst-1/int-2 and c-erbB-2/ear-1

Tsuda H;Hirohashi S;Shimosato Y;Hirota T.
Cancer Research (1989)

471 Citations

Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer.

Hiromi Sakamoto;Kimio Yoshimura;Norihisa Saeki.
Nature Genetics (2008)

421 Citations

cDNA sequence of human transforming gene hst and identification of the coding sequence required for transforming activity.

Masanori Taira;Teruhiko Yoshida;Kiyoshi Miyagawa;Hiromi Sakamoto.
Proceedings of the National Academy of Sciences of the United States of America (1987)

379 Citations

K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes.

Yutaka Hattori;Hiroki Odagiri;Hiroshi Nakatani;Kiyoshi Miyagawa.
Proceedings of the National Academy of Sciences of the United States of America (1990)

344 Citations

Transforming gene from human stomach cancers and a noncancerous portion of stomach mucosa.

Hiromi Sakamoto;Midori Mori;Masanori Taira;Teruhiko Yoshida.
Proceedings of the National Academy of Sciences of the United States of America (1986)

335 Citations

Genomic sequence of hst, a transforming gene encoding a protein homologous to fibroblast growth factors and the int-2-encoded protein.

Teruhiko Yoshida;Kiyoshi Miyagawa;Hiroki Odagiri;Hiromi Sakamoto.
Proceedings of the National Academy of Sciences of the United States of America (1987)

333 Citations

Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue.

Yokota J;Yamamoto T;Miyajima N;Toyoshima K.
Oncogene (1988)

324 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Hiromi Sakamoto

Setsuo Hirohashi

Setsuo Hirohashi

National Cancer Research Institute, UK

Publications: 48

Tatsuhiro Shibata

Tatsuhiro Shibata

University of Tokyo

Publications: 45

Jun Yokota

Jun Yokota

National Cancer Research Institute, UK

Publications: 45

Keitaro Matsuo

Keitaro Matsuo

Nagoya University

Publications: 42

Takashi Sugimura

Takashi Sugimura

National Cancer Centre

Publications: 38

Tetsuya Mitsudomi

Tetsuya Mitsudomi

Kindai University

Publications: 36

Koji Tsuta

Koji Tsuta

Kansai Medical University

Publications: 32

Stephen J. Chanock

Stephen J. Chanock

National Institutes of Health

Publications: 31

Yasushi Yatabe

Yasushi Yatabe

Nagoya University

Publications: 31

Angie Rizzino

Angie Rizzino

University of Nebraska Medical Center

Publications: 31

Shoichiro Tsugane

Shoichiro Tsugane

National Cancer Research Institute, UK

Publications: 30

Hongbing Shen

Hongbing Shen

Nanjing Medical University

Publications: 30

Teruhiko Yoshida

Teruhiko Yoshida

National Cancer Research Institute, UK

Publications: 29

Masaaki Terada

Masaaki Terada

National Cancer Research Institute, UK

Publications: 29

Masayuki Yamamoto

Masayuki Yamamoto

Tohoku University

Publications: 29

Pasi A. Jänne

Pasi A. Jänne

Harvard University

Publications: 28

Trending Scientists

Jason Nieh

Jason Nieh

Columbia University

Matthias Hollick

Matthias Hollick

Technical University of Darmstadt

Manuel Fähndrich

Manuel Fähndrich

Google (United States)

Jaideep Motwani

Jaideep Motwani

Grand Valley State University

Aaron J. Shenhar

Aaron J. Shenhar

Rutgers, The State University of New Jersey

Giambattista Giacomin

Giambattista Giacomin

Université Paris Cité

Holger R. Maier

Holger R. Maier

University of Adelaide

Hans-Herbert Brintzinger

Hans-Herbert Brintzinger

University of Konstanz

Guang-Ling Song

Guang-Ling Song

Xiamen University

John R. Stinchcombe

John R. Stinchcombe

University of Toronto

Shigehiko Uni

Shigehiko Uni

University of Malaya

Guillermo Giménez-Gallego

Guillermo Giménez-Gallego

Centro de Investigaciones Biológicas

Peter F. Rawson

Peter F. Rawson

University College London

Kevin R. Gurney

Kevin R. Gurney

Northern Arizona University

John A. Dani

John A. Dani

University of Pennsylvania

Jeanne M. Clark

Jeanne M. Clark

Johns Hopkins University School of Medicine

Something went wrong. Please try again later.